This inventor holds 6 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignee: Aobiome LLC. Active years: 2017-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2024
Title: Spiros Jamas: Innovator in Ammonia-Oxidizing Bacteria
Introduction
Spiros Jamas is a notable inventor based in Cambridge, MA (US), recognized for his contributions to the field of biotechnology. He holds a total of 6 patents, focusing on innovative methods and applications involving ammonia-oxidizing bacteria.
Latest Patents
One of his latest patents is for an optimized strain of ammonia-oxidizing bacteria designated as D23, D23-100, or AOB D23-100. This strain exhibits desirable properties, such as the ability to suppress the growth of pathogenic bacteria and an enhanced capacity to produce nitric oxide and its precursors. This innovation has potential applications in treating diseases associated with low nitrite levels, skin diseases, and infections caused by pathogenic bacteria. Another significant patent involves a method for treating skin disorders, such as acne vulgaris, by administering ammonia-oxidizing bacteria topically. This method provides a novel approach to managing skin conditions through the application of specialized bacterial preparations.
Career Highlights
Spiros Jamas is currently associated with Aobiome LLC, where he continues to advance his research and development efforts in the field of microbiology. His work has garnered attention for its potential to revolutionize treatments for various health conditions.
Collaborations
He collaborates with notable colleagues, including David R. Whitlock and Larry Weiss, who contribute to the innovative research environment at Aobiome LLC.
Conclusion
Spiros Jamas stands out as an influential inventor in the realm of biotechnology, particularly through his work with ammonia-oxidizing bacteria. His patents reflect a commitment to developing effective treatments for skin disorders and other health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile